Insured? You're more likely to survive cancer through immunotherapy treatment
Powerful new immunotherapies are offering fresh hope for patients with many different types of cancer.
Jul 9, 2025
0
16
MeSH tree: C12.050.351.937.820
Powerful new immunotherapies are offering fresh hope for patients with many different types of cancer.
Jul 9, 2025
0
16
Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma (ChRCC) and those that are present are indifferent to the tumor threat and traditional ...
Jul 3, 2025
0
27
Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins—molecules that transport fat in blood—which enriches cancer cells with an antioxidant shield to survive stress, according to new research ...
Jun 12, 2025
0
29
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.
May 29, 2025
0
29
Researchers have uncovered that some childhood cancers have a substantially higher number of DNA changes than previously thought, changing the way we view children's tumors and possibly opening up new or repurposed treatment ...
May 29, 2025
0
52
A study, led by experts at the University of Nottingham, has found that young people suffering from certain types of cancer, such as bone tumors, are experiencing lengthy times to diagnosis. The Childhood Cancer Diagnosis ...
May 28, 2025
0
16
A research team at the University of Würzburg has gained new insights into the development of kidney tumors in young children. These enable a better risk assessment and could form the basis for targeted screening and improved ...
May 27, 2025
0
26
In the United States, breast, colorectal, endometrial, pancreatic, and kidney cancers are becoming increasingly common among people under age 50, according to a study published in Cancer Discovery.
May 8, 2025
0
25
An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict which kidney cancer patients will benefit from anti-angiogenic therapy, a class of treatments that's ...
Apr 24, 2025
0
20
A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a ...
Apr 12, 2025
0
74